SUMMARY
- Medikabazaar has appointed Dinesh Lodha as Group CEO, bringing over 20 years of medtech industry experience to the role.
- The platform supports over 10,000 medical centers and 30,000 independent doctors with its comprehensive range of medical supplies and services.
- In April 2022, Medikabazaar raised $65 million, valuing the company at $700 million, with a notable 2.74X increase in operating gross revenue to Rs 1,552.53 crore in FY22.
Medikabazaar, a leading B2B medical supply chain platform, has announced the appointment of Dinesh Lodha as its new Group CEO. Lodha, who brings over 20 years of experience in the medtech industry, has held prominent leadership roles across various sectors, including FMCG and healthcare. His extensive background includes managing large-scale B2B and B2C operations with multinational and private equity-led companies.
Medikabazaar, founded by Vivek Tiwari and Ketan Malkan, offers a comprehensive platform that enables hospitals and medical establishments to search for medical supplies, compare specifications, and view real-time pricing. The platform features a wide range of products, including hospital devices, medical consumables, and dental tools. Medikabazaar serves over 10,000 medical centers and 30,000 independent doctors and clinics, providing a B2B marketplace, AI-ML-powered SaaS solutions, medical financing, full-stack procurement models, and asset management platforms for medical equipment.
In April 2022, Medikabazaar secured $65 million in a funding round led by Lighthouse India Fund III, valuing the company at $700 million. The company’s operating gross revenue surged 2.74 times to Rs 1,552.53 crore in FY22, up from Rs 564.7 crore in FY21, according to The Kredible.
